PT2123276E - Composição farmacêutica que contem um derivado de pirazina, e processo de utilização de um derivado de pirazina em associação - Google Patents

Composição farmacêutica que contem um derivado de pirazina, e processo de utilização de um derivado de pirazina em associação

Info

Publication number
PT2123276E
PT2123276E PT87112678T PT08711267T PT2123276E PT 2123276 E PT2123276 E PT 2123276E PT 87112678 T PT87112678 T PT 87112678T PT 08711267 T PT08711267 T PT 08711267T PT 2123276 E PT2123276 E PT 2123276E
Authority
PT
Portugal
Prior art keywords
pyrazine derivative
combination
pharmaceutical composition
pyrazine
derivative
Prior art date
Application number
PT87112678T
Other languages
English (en)
Inventor
Masako Maekawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PT2123276E publication Critical patent/PT2123276E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT87112678T 2007-02-16 2008-02-14 Composição farmacêutica que contem um derivado de pirazina, e processo de utilização de um derivado de pirazina em associação PT2123276E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007035975 2007-02-16

Publications (1)

Publication Number Publication Date
PT2123276E true PT2123276E (pt) 2013-01-16

Family

ID=39690101

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87112678T PT2123276E (pt) 2007-02-16 2008-02-14 Composição farmacêutica que contem um derivado de pirazina, e processo de utilização de um derivado de pirazina em associação

Country Status (21)

Country Link
US (1) US8759354B2 (pt)
EP (1) EP2123276B1 (pt)
JP (1) JP5255456B2 (pt)
KR (1) KR101479083B1 (pt)
CN (1) CN101610772B (pt)
AU (1) AU2008215397B2 (pt)
BR (1) BRPI0807597B8 (pt)
CA (1) CA2677905C (pt)
CY (1) CY1113435T1 (pt)
DK (1) DK2123276T3 (pt)
ES (1) ES2396595T3 (pt)
HR (1) HRP20130111T1 (pt)
IL (1) IL200285A (pt)
MX (1) MX2009008779A (pt)
NZ (1) NZ578989A (pt)
PL (1) PL2123276T3 (pt)
PT (1) PT2123276E (pt)
RU (1) RU2463051C2 (pt)
SI (1) SI2123276T1 (pt)
WO (1) WO2008099874A1 (pt)
ZA (1) ZA200905536B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2417617A4 (en) * 2009-04-09 2012-09-26 Lg Electronics Inc DISPLAY APPARATUS
CN104777301B (zh) * 2010-05-10 2018-04-20 中央研究院 具有抗流感活性的扎那米韦膦酸酯同类物及流感病毒的奥司他韦易感性的测定
PL2623498T3 (pl) * 2010-09-30 2016-05-31 Toyama Chemical Co Ltd Sól sodowa 6-fluoro-3-hydroksy-2-pirazynokarboksamidu
HUE026794T2 (en) 2010-09-30 2016-07-28 Toyama Chemical Co Ltd The oleum salt of 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
WO2014186465A1 (en) * 2013-05-14 2014-11-20 Biocryst Pharmaceuticals, Inc. Anti-influenza compositions and methods
CN104402833B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 含有环丁烷取代基的吡嗪类化合物及其组合物及用途
CN104447585B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 吡嗪类化合物及其组合物及用途
CN104447583B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 含有环丁烷取代基的吡嗪类化合物及其组合物及用途
CN104447584B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 含有环丁烷取代基的吡嗪类化合物及其组合物及用途
CN104496918B (zh) * 2014-12-10 2016-08-24 广东东阳光药业有限公司 吡嗪衍生物及其用途
CN104817511B (zh) * 2015-04-27 2017-04-19 济南大学 一种丁烯二酸酐制备法匹拉韦关键中间体的方法
RU2745071C2 (ru) * 2015-12-15 2021-03-18 Сионоги Энд Ко., Лтд. Лекарственный препарат для лечения гриппа, характеризующийся тем, что в нем объединены ингибитор кэп-зависимой эндонуклеазы и лекарственное средство против гриппа
WO2020138067A1 (ja) 2018-12-25 2020-07-02 富士フイルム富山化学株式会社 ピラジン誘導体と細胞内におけるピラジン誘導体リボース三リン酸体の量を増加させる化合物とを組み合わせてなるrnaウイルス感染症治療剤
JP7449379B2 (ja) 2020-05-27 2024-03-13 富士フイルム富山化学株式会社 ピラジン誘導体とチオプリン誘導体を組み合わせてなるrnaウイルス感染症治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01197437A (ja) * 1988-01-29 1989-08-09 Dso Pharmachim 抗ウイルス薬
BRPI9913097B8 (pt) * 1998-08-20 2021-05-25 Fujifilm Toyama Chemical Co Ltd derivado heterocíclico de carboxamida contendo nitrogênio ou um sal do mesmo
WO2003015798A1 (en) 2001-08-14 2003-02-27 Toyama Chemical Co., Ltd. Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
JP2005354833A (ja) * 2004-06-11 2005-12-22 Fujinon Corp アクチュエータ
JP4689989B2 (ja) * 2004-08-27 2011-06-01 オリンパス株式会社 振動波リニアモータ及びそれを用いたレンズ装置
DE102008031715A1 (de) 2008-07-04 2010-01-07 Henkel Ag & Co. Kgaa Haarkonditionierende Mittel mit Imidazolinen

Also Published As

Publication number Publication date
JP5255456B2 (ja) 2013-08-07
US8759354B2 (en) 2014-06-24
PL2123276T3 (pl) 2013-04-30
RU2463051C2 (ru) 2012-10-10
JPWO2008099874A1 (ja) 2010-05-27
KR101479083B1 (ko) 2015-01-07
IL200285A0 (en) 2010-04-29
US20100087447A1 (en) 2010-04-08
EP2123276B1 (en) 2012-11-28
HRP20130111T1 (hr) 2013-02-28
ES2396595T3 (es) 2013-02-22
ZA200905536B (en) 2010-10-27
KR20090121289A (ko) 2009-11-25
WO2008099874A1 (ja) 2008-08-21
CN101610772B (zh) 2013-01-16
CN101610772A (zh) 2009-12-23
SI2123276T1 (sl) 2013-03-29
CA2677905A1 (en) 2008-08-21
RU2009134516A (ru) 2011-03-27
AU2008215397B2 (en) 2012-09-06
EP2123276A1 (en) 2009-11-25
CY1113435T1 (el) 2016-06-22
IL200285A (en) 2014-06-30
BRPI0807597B8 (pt) 2021-05-25
BRPI0807597B1 (pt) 2021-03-02
DK2123276T3 (da) 2013-01-02
CA2677905C (en) 2015-03-24
EP2123276A4 (en) 2011-05-18
MX2009008779A (es) 2009-11-05
NZ578989A (en) 2011-07-29
BRPI0807597A2 (pt) 2014-05-06
AU2008215397A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
IL200285A0 (en) Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
IL275854A (en) Pharmaceutical composition and its administration
PT1902706T (pt) Composições farmacêuticas estáveis de tetraciclinas em solução, seu método de obtenção e suas utilizações
HK1117164A1 (en) Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
HK1149268A1 (en) Pyrazine derivatives and their use as protein kinase inhbitors
EP2230241A4 (en) TETRAHYDROIMIDAZOÝ1,5-A¨PYRAZINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND MEDICAL USES THEREOF
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
IL203292A (en) History of n-indazolil affluent, process for preparation, intermediates obtained in this process and pharmacological preparations containing the history
IL200206A (en) The history of quinaxaline, their preparation and their pharmaceutical preparations
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL213570A (en) History 8 - Alkoxy - s - Triazolo [5,1 - a] pyridine and pharmaceutical preparations containing them
AP2590A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
EP2211851A4 (en) LAMININS, DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND METHOD FOR THEIR THERAPEUTIC USE
EP2345416A4 (en) PHARMACEUTICAL COMPOSITION FOR CLEANING VENES AND MANUFACTURING METHOD THEREFOR
HK1143590A1 (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics 7--18-
EP2322505A4 (en) 1-ADAMANTYLAZETIDIN-2-ON DERIVATIVE, PREPARATION THEREOF AND PHARMACEUTICAL PREPARATION THEREWITH
EP2279999A4 (en) RETINOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1152038A1 (en) Azetidine derivatives, their preparation and their application in therapy
IL207298A (en) A derivative of benzenesulfonamide, pharmaceutical preparations containing it and its uses
HK1155062A1 (en) Pharmaceutical composition and combined agent
EP2348019A4 (en) 1,2-DIAZETTIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME
IL215551A (en) An indolite derivative, a pharmaceutical preparation containing it and its uses
HK1144093A1 (en) Sophocarpine-series derivative, and preparation method and use thereof
EP2484675A4 (en) NEW PHENYLPYRIDINE DERIVATIVE AND MEDICAMENT THEREOF